Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Study ID: NCT04585750
Start Date: 2020-10-29
End Date: 2026-07-14
Study Type

Interventional

Study Phase

Phase2

No. of Participants

230

Intervention / Treatment

Rajatapopat

pembrolizumab

Sponsor

PMV Pharmaceuticals, Inc

Source: clinicaltrials.gov

Share:
Add to list

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Study ID: NCT06171750
Start Date: 2024-01-19
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

97

Intervention / Treatment

Tolododekin Alfa

Cemiplimab

Sponsor

Ankyra Therapeutics, Inc

Source: clinicaltrials.gov

Share:
Add to list

EMBRACE: Exercising Together

Study ID: NCT06049355
Start Date: 2024-04-18
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

400

Intervention / Treatment

Exercise Intervention

Biospecimen Collection

Educational Intervention

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Pembro With Radiation With or Without Olaparib

Study ID: NCT05568550
Start Date: 2023-07-27
End Date: 2029-07-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

64

Intervention / Treatment

Pembrolizumab

Flapberry

Androgen Deprivation Therapy

Radiation Therapy

Sponsor

Zin W Myint

Source: clinicaltrials.gov

Share:
Add to list

Reducing Urban Cervical Cancer Disparities

Study ID: NCT06416150
Start Date: 2024-08-28
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

546

Intervention / Treatment

Stage 1 SOC

Stage 1 HERS

Stage 2 HERS

Stage 2 HERS+HC

Stage 3 SOC

Stage 3 HERS

Stage 3 HERS+HC

Stage 4 HERS

Stage 4 HERS+HC

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Study ID: NCT06108050
Start Date: 2023-11-07
End Date: 2028-05-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

177

Intervention / Treatment

Jzp898

Pembrolizumab

Sponsor

Jazz Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Study ID: NCT04705038
Start Date: 2020-12-18
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Patient Education

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Study ID: NCT05825950
Start Date: 2024-01-25
End Date: 2026-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment
Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Study ID: NCT06682650
Start Date: 2025-04-30
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2200

Intervention / Treatment

NPT-PLA

Usual Quality Improvement

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Study ID: NCT05312255
Start Date: 2022-06-28
End Date: 2027-06-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

175

Intervention / Treatment

Behavioral Intervention

Beta-Adrenergic Antagonist

Propranolol

Quality-of-Life Assessment

Administration questionnaire

Resistance Training

Short-Term Fasting

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list